Deutsches Conn-Register

Else Kröner-Fresenius Conn-Register

Publikationen

Originalarbeiten:

Reincke M, Rump LC, Quinkler M, Hahner S, Diederich S, Lorenz R, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Meisinger C, Holle R, Endres S; for the Participants of the German Conn's Registry. Risk factors associated with a low glomerular filtration rate in primary aldosteronism.
J Clin Endicrinol Metab 2009; 94 (3): 869-875

Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, Allolio B, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Endres S, Quinkler M; fort he participants of the German Conn´s Registry. Cardio- and cerebrovascular comorbidities of hypo- and normokalemic primary aldosteronism: results of the German Conn´s Registry.
J Clin Endocrinol Metab 2009

Schirpenbach C, Segmiller F, Diederich S, Hahner S, Lorenz R, Rump LC, Seufert J, Quinkler M, Bidlingmaier M, Beuschlein B, Endres S, Reincke M, Diagnostik und Therapie des primären Hyperaldosteronismus in Deutschland: Ergebnisse des deutschen Conn-Registers an 555 Patienten.
Dtsch. Ärzteblatt 2009.

Born-Frontsberg E, Reincke M, Beuschlein F, Quinkler M Tumour size of Conn´s adenoma and comorbidities.
Hormone and Metabolic Research 2009

Reincke M, Endres S. Metabolic complications in primary aldosteronism.
Ann Endocrinol 2009

Fischer E, Degenhart C, Reincke M. Improving adrenal venous sampling in primary aldosteronism.
Expert Review of Endocrinology & Metabolism, September 2012, Vol. 7, No. 5, Pages 531-540.

Fourkiotis VG, Vonend O, Diederich S, Fischer E, Lang K, Endres S, Beuschlein F, Willenberg HS, Rump LC, Allolio B, Reincke M, Quinkler M. Effectiveness of Eplerenone or Spironolactone treatment in preserving renal function in primary aldosteronism.
Eur J Endocrinol. 2012 Oct 2.

Künzel HE, Apostolopoulou K, Pallauf A, Gerum S, Merkle K, Schulz S, Fischer E, Brand V, Bidlingmaier M, Endres S, Beuschlein F, Reincke M. Quality of life in patients with primary aldosteronism: Gender differences in untreated and long-term treated patients and associations with treatment and aldosterone.
J Psychiatr Res. 2012 Sep 24.

Fischer E, Hanslik G, Pallauf A, Degenhart C, Linsenmaier U, Beuschlein F, Bidlingmaier M, Mussack T, Ladurner R, Hallfeldt K, Quinkler M, Reincke M. Prolonged Zona Glomerulosa Insufficiency Causing Hyperkalemia in Primary Aldosteronism after Adrenalectomy.
J Clin Endocrinol Metab. 2012 Aug 14.

Reincke M, Fischer E, Gerum S, Merkle K, Schulz S, Pallauf A, Quinkler M, Hanslik G, Lang K, Hahner S, Allolio B, Meisinger C, Holle R, Beuschlein F, Bidlingmaier M, Endres S; for the Participants of the German Conn's Registry-Else Kröner-Fresenius-Hyperaldosteronism Registry. Observational Study Mortality in Treated Primary Aldosteronism: The German Conn's Registry.
Hypertension. 2012 Sep;60(3):618-624.

Apostolopoulou K, Künzel HE, Gerum S, Merkle K, Schulz S, Fischer E, Pallauf A, Brand V, Bidlingmaier M, Endres S, Beuschlein F, Reincke M. Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: A cross-sectional study.
World J Biol Psychiatry. 2012 May 8.

Hannemann A, Bidlingmaier M, Friedrich N, Manolopoulou J, Spyroglou A, Völzke H, Beuschlein F, Seissler J, Rettig R, Felix SB, Biffar R, Döring A, Meisinger C, Peters A, Wichmann HE, Nauck M, Wallaschofski H, Reincke M. Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies.
Eur J Endocrinol. 2012 Jul;167(1):7-15.

Rossi GP, Barisa M, Allolio B, Auchus RJ, Amar L, Cohen D, Degenhart C, Deinum J, Fischer E, Gordon R, Kickuth R, Kline G, Lacroix A, Magill S, Miotto D, Naruse M, Nishikawa T, Omura M, Pimenta E, Plouin PF, Quinkler M, Reincke M, Rossi E, Rump LC, Satoh F, Schultze Kool L, Seccia TM, Stowasser M, Tanabe A, Trerotola S, Vonend O, Widimsky J Jr, Wu KD, Wu VC, Pessina AC. The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism.
J Clin Endocrinol Metab. 2012 May;97(5):1606-14.

Boulkroun S, Beuschlein F, Rossi GP, Golib-Dzib JF, Fischer E, Amar L, Mulatero P, Samson-Couterie B, Hahner S, Quinkler M, Fallo F, Letizia C, Allolio B, Ceolotto G, Cicala MV, Lang K, Lefebvre H, Lenzini L, Maniero C, Monticone S, Perrocheau M, Pilon C, Plouin PF, Rayes N, Seccia TM, Veglio F, Williams TA, Zinnamosca L, Mantero F, Benecke A, Jeunemaitre X, Reincke M, Zennaro MC. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.
Hypertension. 2012 Mar;59(3):592-8.

Pallauf A, Schirpenbach C, Zwermann O, Fischer E, Morak M, Holinski-Feder E, Hofbauer L, Beuschlein F, Reincke M. The prevalence of familial hyperaldosteronism in apparently sporadic primary aldosteronism in Germany: a single center experience.
Horm Metab Res. 2012 Mar;44(3):215-20.

Mulatero P, Tauber P, Zennaro MC, Monticone S, Lang K, Beuschlein F, Fischer E, Tizzani D, Pallauf A, Viola A, Amar L, Williams TA, Strom TM, Graf E, Bandulik S, Penton D, Plouin PF, Warth R, Allolio B, Jeunemaitre X, Veglio F, Reincke M. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.
Hypertension. 2012.

Hannemann A, Wallaschofski H, Lüdemann J, Völzke H, Markus MR, Rettig R, Lendeckel U, Reincke M, Felix SB, Empen K, Nauck M, Dörr M. Plasma aldosterone levels and aldosterone-to-renin ratios are associated with endothelial dysfunction in young to middle-aged subjects.
Atherosclerosis. 2011 Dec;219(2):875-9.

Fischer E, Beuschlein F, Degenhart C, Jung P, Bidlingmaier M, Reincke M. Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn's Registry.
Clin Endocrinol (Oxf). 2012 Apr;76(4):473-7.

Betz MJ, Degenhart C, Fischer E, Pallauf A, Brand V, Linsenmaier U, Beuschlein F, Bidlingmaier M, Reincke M. Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates.
Eur J Endocrinol. 2011 Aug;165(2):301-6.

Vonend O, Ockenfels N, Gao X, Allolio B, Lang K, Mai K, Quack I, Saleh A, Degenhart C, Seufert J, Seiler L, Beuschlein F, Quinkler M, Podrabsky P, Bidlingmaier M, Lorenz R, Reincke M, Rump LC; German Conn's Registry. Adrenal venous sampling: evaluation of the German Conn's registry.
Hypertension. 2011 May;57(5):990-5.

Hannemann A, Meisinger C, Bidlingmaier M, Döring A, Thorand B, Heier M, Belcredi P, Ladwig KH, Wallaschofski H, Friedrich N, Schipf S, Lüdemann J, Rettig R, Peters J, Völzke H, Seissler J, Beuschlein F, Nauck M, Reincke M. Association of plasma aldosterone with the metabolic syndrome in two German populations.
Eur J Endocrinol. 2011 May;164(5):751-8.

Fischer E, Beuschlein F, Bidlingmaier M, Reincke M. Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism.
Rev Endocr Metab Disord. 2011 Mar;12(1):43-8.

Manolopoulou J, Gerum S, Mulatero P, Rossignol P, Plouin PF, Reincke M, Bidlingmaier M. Salivary aldosterone as a diagnostic aid in primary aldosteronism.
Horm Metab Res. 2010 Jun;42(6):400-5.

Hannemann A, Friedrich N, Lüdemann J, Völzke H, Rettig R, Peters J, Reincke M, Döring A, Nauck M, Wallaschofski H. Reference intervals for aldosterone, renin, and the aldosterone-to-renin ratio in the population-based Study of Health in Pomerania (SHIP-1).
Horm Metab Res. 2010 Jun;42(6):392-9.

Reincke M, Meisinger C, Holle R, Quinkler M, Hahner S, Beuschlein F, Bidlingmaier M, Seissler J, Endres S; Participants of the German Conn's Registry. Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry.
Horm Metab Res. 2010 Jun;42(6):435-9.

Tagungsbeiträge:

Schirpenbach C, Reuschl S, Segmiller F, Klempau C, Beuschlein F, Bidlingmaier M, Diederich S, Endres S, Hahner S, Lorenz R, Quinkler M, Rump LC, Reincke M. The National Conn´s registry: Objectives and first results. Exp Clin Endocrinol Diabetes 2006; 115 (Suppl 1): S14
Vortrag - 51. Symposium der Deutschen Gesellschaft für Endokrinologie, 7.-10. März 2007, Salzburg

Schirpenbach C, Reuschl S, Segmiller F, Klempau C, Beuschlein F, Bidlingmaier M, Diederich S, Endres S, Hahner S, Lorenz R, Quinkler M, Rump LC, Seufert J, Reincke M. Nationales Conn-Register: Zielsetzung und erste Ergebnisse
Poster - 113. Kongreß der Deutschen Gesellschaft für Innere Medizin, 14.-18. April 2007, Wiesbaden

Schulz S, Merkle K, Gerum S, Schirpenbach C, Löw A, Beuschlein F, Reincke M. No evidence of higher prevalence of depression in patients with primary aldosteronism than in the normal population.
Poster PS2-03-1. 52. Symposion der Deutschen Gesellschaft für Endokrinologie, 4.-7. März 2009, Gießen

Merkle K, Schulz S, Gerum S, Schirpenbach C, Jung P, Beuschlein F, Reincke M. Blood pressure regulation in patients with primary aldosteronism following adrenalectomy and mineralocorticoid receptor antagonist therapy.
Poster PS2-03-2. 52. Symposion der Deutschen Gesellschaft für Endokrinologie, 4.-7. März 2009, Gießen

Gerum S, Merkle K, Schulz S, Schirpenbach C, Manolopoulou J, Bidlingmaier M, Beuschlein F, Reincke M. Normalization of the aldosterone/renin ratio and potassium levels in patients with primary aldosteronism under long-term therapy with spironolactone. Poster PS2-03-3. 52.
Symposion der Deutschen Gesellschaft für Endokrinologie, 4.-7. März 2009, Gießen

Impressum